In our earlier published in vitro study, CADMN has been reported to exert anti-proliferative and apoptotic action in hepatocellular carcinoma cells (HepG2) through enhancing the ROS accumulation, which lead to an inhibition of NF-κB translocation [15]. Here, NFKB1 is linked to hepatocellular carcinoma.